| answer text |
<p>Clinical commissioning groups are not responsible for ensuring access to advanced
radiotherapy techniques, such as Intensity Modulated Radiotherapy (IMRT). The commissioning
of all radiotherapy in England is the responsibility of NHS England’s Specialised
Commissioning team. Access to IMRT is monitored against a national average access
standard of 25%, performance against this standard is consistently around 45%. From
April 2019, Radiotherapy Networks, working in close partnership with Specialised Commissioners
and Cancer Alliances, will play a key role in increasing access to both advanced and
innovative radiotherapy, as well as ensuring adherence to best practice treatment
protocols.</p>
|
 |
